产品中心-北京博奥森生物技术有限公司

产品编号	BIO0939SM
英文名称	Anti-Ang2 & VEGFA Reference Antibody (Faricimab Biosimilar)
中文名称
别名	Angiopoietin 2 & VEGF-A; Faricimab
抗体来源
克隆类型	Monoclonal
克隆号
交叉反应	Human
产品应用	not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user.
理论分子量	292.8 kDa
检测分子量
性状	Lyophilized
亚型	IgG-like
纯化方法	Protein A
缓冲液	100 mM Pro-Ac 20mM Arg pH 5.0
保存条件	-80°C for 2 years under sterile conditions； -20°C for 1 year under sterile conditions；Avoid repeated freeze-thaw cycles.
注意事项	This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
PubMed	PubMed
产品介绍
产品图片	Anti-ANG2 & VEGFA Reference Antibody (Faricimab) Luciferase Assay was evaluated using VEGFR2-NF-AT HEK293 Cell. The IC50 was approximately 8.449 nM . Anti-ANG2 & VEGFA Reference Antibody (Faricimab)-Proliferation inhibition using HUVEC Cell. The maximum proliferation inhibition rate is about 80% Affinity constant of 1.25E-10M as determined in BLI assay.（Human ANGPT2, His Tag） Immobilized VEGFA Protein at 2 μg/mL can bind Anti-ANG2 & VEGFA Reference Antibody (Faricimab). The purity of Anti-ANG2 & VEGFA Reference Antibody (Faricimab) is more than 95%, determined by SEC-HPLC.